Black Rock Inc. Protagonist Therapeutics, Inc Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Black Rock Inc. holds 5,758,112 shares of PTGX stock, worth $239 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,758,112

Previous 5,569,485 3.39%

Holding current value

$239 Million

Previous $161 Million 23.83%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$24.66 - $34.8 $4.65 Million - $6.56 Million	188,627 Added 3.39%	5,758,112 $200 Million
Q1 2024 May 10, 2024	BUY	$21.79 - $32.15 $557,453 - $822,493	25,583 Added 0.46%	5,569,485 $161 Million
Q4 2023 Feb 13, 2024	BUY	$14.05 - $23.44 $4.42 Million - $7.37 Million	314,477 Added 6.01%	5,543,902 $127 Million
Q3 2023 Nov 13, 2023	BUY	$16.68 - $23.66 $3.67 Million - $5.21 Million	220,152 Added 4.39%	5,229,425 $87.2 Million
Q2 2023 Aug 11, 2023	BUY	$18.02 - $29.36 $10.9 Million - $17.8 Million	607,056 Added 13.79%	5,009,273 $138 Million
Q1 2023 May 12, 2023	BUY	$10.78 - $25.38 $8.09 Million - $19 Million	750,060 Added 20.54%	4,402,217 $101 Million
Q4 2022 Feb 13, 2023	BUY	$7.36 - $11.17 $1.4 Million - $2.12 Million	189,773 Added 5.48%	3,652,157 $39.8 Million
Q3 2022 Nov 14, 2022	BUY	$7.86 - $11.71 $58,698 - $87,450	7,468 Added 0.22%	3,462,384 $29.2 Million
Q2 2022 Aug 12, 2022	BUY	$7.06 - $25.52 $1.47 Million - $5.33 Million	208,742 Added 6.43%	3,454,916 $27.3 Million
Q1 2022 May 12, 2022	SELL	$23.34 - $36.08 $827,683 - $1.28 Million	-35,462 Reduced 1.08%	3,246,174 $76.9 Million
Q4 2021 Feb 10, 2022	BUY	$17.63 - $37.1 $1.45 Million - $3.05 Million	82,140 Added 2.57%	3,281,636 $112 Million
Q3 2021 Nov 09, 2021	BUY	$12.95 - $49.69 $2.06 Million - $7.9 Million	158,955 Added 5.23%	3,199,496 $56.7 Million
Q2 2021 Aug 11, 2021	BUY	$25.57 - $44.88 $77.7 Million - $136 Million	3,040,541 New	3,040,541 $136 Million

Others Institutions Holding PTGX

# of Institutions

248

Shares Held

56.7M

Call Options Held

76.3K

Put Options Held

114K

View Full List

About Protagonist Therapeutics, Inc

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.04B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

More about PTGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account